Advances in Technology
The U.S. Food and Drug Administration has announced the establishment of a Rare Disease Innovation Hub. The Hub will connect and engage the rare disease community; help the community navigate…
The Golden West Chapter celebrates the Food and Drug Administrationā€™s (FDA) announcement of approval of RELYVRIO (formerly AMX0035) as a new treatment for adults living with amyotrophic lateral sclerosis (ALS),…
Today, we filed comments with the FDA imploring them to ask the right question when it reconvenes its advisory committee in September to consider a new drug application (NDA) for…